General Principles for Evaluation of New Interventional Technologies and Devices

Journal of Vascular and Interventional Radiology

Volumn 14, Issue 9 PART 2, 2003, Pages

  Sacks, David ^a   Chairman, Committee ^a   Marinelli, David L ^a   Martin, Louis G ^a   Spies, James B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 17144363771     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000094614.61428.67     Document Type: Article

References (21)

1. Oxman A.D., Sackett D.L., and Guyatt G.H. Users' guide to the medical literature. I. How to get started. JAMA 270 (1993) 2093-2095
2. Guyatt G.H., Sackett D.L., and Cook D.J. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid?. JAMA 270 (1993) 2598-2602
3. Guyatt G.H., Sackett D.L., and Cook D.J. Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients?. JAMA 271 (1994) 59-63
4. Woolf S.H. Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med 152 (1992) 946-952
5. Cook D.J., Guyatt G.H., Laupacis A., and Sackett D.L. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 102 suppl (1992) 305S-311S
6. Interventional Cardiology Devices Branch, Division of Cardiovascular, Respiratory and Neurology Devices, Office of Device Evaluation of the Food and Drug Administration. Guidance for the submission of research and marketing applications for interventional cardiology devices. May 1993.
7. Begg C.B., and McNeil B.J. Assessment of radiologic tests: Control of bias and other design considerations. Radiology 167 (1988) 565-569
8. Guyatt G., Drummond M., Feeny D., et al. Guidelines for the clinical and economic evaluation of health care technologies. Soc Sci Med 22 (1986) 393-408
9. McLean G.K., Burke D.R., and Marinelli D.L. Comment on the clinical appropriateness of an emerging technology. Radiology 172 (1989) 941-942
10. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 34 (1976) 585-612
11. Schulz K.F., Chalmers I., Hayes R.J., and Altman D.G. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 (1995) 408-412
12. Grunkemeier G.L., and Starr A. Alternatives to randomization in surgical studies. J Heart Valve Dis 1 (1992) 142-151
13. Bonchek L.I. Are randomized trials appropriate for evaluating new operations?. N Engl J Med 301 (1979) 44-45
14. Grimes D.A. Technology follies: the uncritical acceptance of medical innovation. JAMA 269 (1993) 3030-3033
15. McLean G.K. Percutaneous peripheral atherectomy. J Vasc Interv Radiol 4 (1993) 465-480
16. Vroegindeweij D., Tielbeek A.V., Buth J., Schol F.P.G., Hop W.C.J., and Landman G.H.M. Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. J Vasc Surg 21 (1995) 255-269
17. Tielbeek A.V., Vroegindeweij D., Buth J., and Landman G.H.M. Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. J Vasc Interv Radiol 7 (1996) 837-844
18. Baim D.S., Dent K.M., King S.B., et al. Evaluating new devices: acute (in-hospital) results from the new approaches to coronary intervention registry. Circulation 89 (1994) 471-481
19. Hertzer N.R. The natural history of peripheral vascular disease: implications for its management. Circulation 83 suppl (1991) I12-I19
20. The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA 272 (1994) 1926-1931
21. Begg C., Cho M., Eastwood S., et al. Improving the quality of reporting in randomized trials: the CONSORT statement. JAMA 276 (1996) 637-639